SABSW vs VMC · P/E 0.0 vs P/E 35, rev $7.94B
SAB Biotherapeutics Inc (SABSW) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
SABSW does not have a complete income-statement cache yet.
Latest reported VMC revenue for 2025-12-31 was $7.94B. Net income was $1.08B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
SABSW currently screens at market cap $0 and trailing P/E 0.0. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the SABSW and VMC stock pages for the full models.
Not investment advice.